Venkateswarlu Tanneru builds resilient cloud infrastructure using predictive failure systems, blending aeronautical ...

Nu Holdings is reporting Q1 results today after facing a 23% share decline since February as investors await clarity on whether the company can justify its investment spending while managing credit ...

Kappa Kappa wins the 2025 Raven Run Stakes at Keeneland Coady Media/Christine Hayden Kappa Kappa wins the 2025 Raven Run Stakes at Keeneland Coady Media/Christine Hayden Kappa Kappa wins the 2025 ...

Nu Holdings (NU) stock slid 10% in Thursday after-hours trading after the Brazilian fintech's Q1 earnings and revenue failed to meet Wall Street expectations. Q1 GAAP EPS of $0.18, missing the average ...

NU is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of NU shares has decreased $0.51 since the market last closed. This is a 4.27% ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

NU shares are down 11.46% over the past week, 14.25% over the past month, and 23.42% year to date, sliding from a February high near $18.98 toward the 52-week low of $11.71. The selloff tracks ...

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward ...

I purchased the original LumiSpa in June, 2022. A few days after the 1-year mark, in June, 2023, it quit working. It would not charge, or, if it did, it would not hold a charge. At the time, I ...

Nu Holdings NU reported first-quarter financial results Thursday after market close. Here are the key highlights. • Nu Holdings stock is testing key support levels. Why is NU stock at lows? Nu ...

Free light chain (FLC) kappa and lambda Assays for Atellica ® NEPH 630*, BN TM II, and BN ProSpec ® Systems are developed for more reliable managment of patients with monoclonal gammopathies. Improved ...